Colon carcinoma rarely metastasizes to the breast and it is usually associated with a poor prognosis. Even rarer is metastatic seeding of colon cancer cells in an intramammary location after surgery. Including a primary breast malignancy in the differential diagnosis of such cases is mandatory. We report a rare case of double seeding implantation of colon adenocarcinoma inside the breast parenchyma and intercostal muscles 6 years after resection of a pulmonary metastasis from colon adenocarcinoma. The metastasis was revealed by the presence of bone metaplasia in the intercostal muscles. We discuss how negative immunostaining for estrogen receptors, progesterone receptors, and HER-2, along with the immunohistochemical pattern of cytokeratin (CK) 20+/7−/5− and CDX2-positive immunostaining, excludes a primary breast malignancy, namely, a "matrixproducing" carcinoma, from the differential diagnosis. We also present the hypothesis of a paracrine pathogenetic mechanism to explain the bone metaplasia.
Introduction
Breast metastases from colon adenocarcinoma are very rare [1] [2] [3] [4] and may be confused with a primary neoplasm of the breast. Because the treatment and outcome of primary and secondary malignancies of the breast are completely different, an accurate diagnosis is important. The expression of estrogen receptors (ERs) and progesterone receptors (PRs) often suggests the primary breast origin of a malignancy, but certain breast carcinomas are negative for these receptors. Immunohistochemical assay using the anti-cytokeratin-7 (CK7) and anti-cytokeratin-20 (CK20) antibodies has been introduced to assist in differentiating primary and metastatic neoplasias. Typical CK7/CK20 patterns are present in adenocarcinomas of different origin. In fact, most breast carcinomas show a CK7+/CK20− pattern, whereas most colon adenocarcinomas are CK7−/CK20+. 5 Expression of CK5 has been reported in basal-like breast carcinomas, which are negative for ER, PR, and HER-2 expression and enclose an even rarer histotype, known as a "matrix-producing" carcinoma, showing cartilaginous and/or bone metaplasia. [6] [7] [8] We report a case of breast metastatic seeding of colon cancer cells, developing into bone metaplasia, in a woman who had undergone resection of lung metastasis from colon adenocarcinoma 6 years earlier. The surgical indications for pulmonary metastasis resection were the resectability of the lung lesion, and the absence of any sign of local recurrence of the primary lesion or of extrapulmonary lesions. 9 The rarity of intramammary metastatic seeding, the long interval since the lung metastasis resection, and the unusual histological picture, with bone metaplasia in one of the metastatic sites, made it diffi cult to differentiate the colon cancer metastasis from a primary "matrixproducing" breast carcinoma. Thus, we stress the importance of immunohistochemistry through the presentation of this case.
Case Report
A 76-year-old woman was referred to us for investigation of a mammary nodule, which had been misdiagnosed as breast ductal infi ltrating carcinoma G2, based on needle core biopsy fi ndings at another hospital. Clinically, the nodule was 1.6 cm in maximum diameter and located within the breast parenchyma, peripherally, between the upper and the lower external quadrant.
Hereafter we refer to this nodule as "nodule A." A breast X-ray showed radio-opacity of the unclear margins of the nodule in the external upper segment of the right breast, not far from the chest wall (Fig. 1) .
The patient reported that about 7 years previously, she had undergone a left hemicolectomy for adenocarcinoma of the descending colon, pT3 N1 M0 (TNM Stage IIIB), at another hospital, and that histopathological examination had revealed vascular invasion. Fourteen months later, a single lung metastasis from the adenocarcinoma of the colon was detected in the upper lobe of the right lung. Computed tomography (CT) scan and histological examination revealed that this mass was deeply located far from the pleural surface of the lung. Thus, the patient underwent a wedge resection of the upper lobe of the right lung, with placement of a drainage tube, which exited across the fourth intercostal space, consistent with the location of the skin scar. From the time of the second operation until the discovery of the breast nodule, no further treatment was given and the patient was not followed up.
On admission, the values of the tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigens 15-3, 125, and 19-9 were within the normal range. Chest radiography, abdominal ultrasonography, and whole-body bone scintigraphy showed no lesions indicative of metastasis. Considering the age of the patient, we decided to perform an upper-external quadrantectomy of the right breast. After removing this quadrant, we palpated another nodular swelling about 3 cm in diameter in the chest wall below the pectoral muscles. Hereafter we refer to this nodule as "nodule B." Raising this nodule with a divaricator revealed a tumor within the fourth intercostal space, in the intercostal muscle, from which it was then isolated and removed. The patient was sent home on day 2 after an uneventful recovery.
Histological examination was performed on formalinfi xed, paraffi n-embedded hematoxylin-eosin-stained sections. Both nodules consisted of neoplastic, moderately differentiated gland tissue, apparently compatible with the diagnosis of ductal infi ltrating carcinoma G2. No excess mucous production was observed. Interestingly, nodule B contained large areas of bone metaplasia, consisting of fully matured bone metaplastic tissue, with rows of osteoblasts along the edge of the osseous trabeculae (Fig. 2a,b) . No bone metaplasia was seen in nodule A. Immunostaining was negative for ERs, PRs, and HER-2 in both nodules. Reports of colon adenocarcinoma metastatic to the lungs justifi ed further immunohistochemical analysis with CK7, CK20, CK5, and CDX2. In both nodules, a CK20+/CK7−/CK5−/CDX2+ immunohistochemical pattern could be seen (Fig. 2c-e) . Moreover, in nodule B several slender and atrophic muscle fi bers, located very close to the metaplastic bone trabeculae and to the neoplastic glands, were highlighted by using anti-desmin antibody (Fig. 2f) . Based on these fi ndings, we excluded primary breast malignancy and diagnosed intestinal carcinoma metastasis.
The hypothesis of metastatic seeding of malignant cancer cells was proposed, even though 5 years had elapsed since the pulmonary wedge resection, because the site of the two nodules coincided with the path and the skin scar of the drainage tube. Histological sections of the previously resected primary colon tumor and lung metastases were revised, but no bone metaplasia was observed. The patient is still alive without further evidence of metastases after a 1.5 year follow-up.
Discussion
The seeding of malignant cancer cells along the path of the drainage tube is a rare complication of some surgical procedures and of percutaneous drainage. It is most frequently reported after percutaneous biliary drainage for pancreatic carcinoma 10, 11 and cholangiocarcinoma, [12] [13] [14] [15] [16] [17] after laparotomy resection of colorectal cancer 18 and, occasionally, for carcinoma of the uterine cervix. 19, 20 The chest wall implantation of cancer cells at the drainage tube site has been reported after lobectomy, 21 pericardiocentesis, 22 and needle aspiration biopsy 23 in patients with pulmonary malignancies. According to a recent report, catheter-tract metastasis was found in 6.7% of 45 patients treated with indwelling pleural catheters for malignant pleural effusions. 24 The skin is the most common site of the implantation. To our knowledge, intramammary dissemination has only ever been reported in one patient after percutaneous Fig. 2. a, b The intramammary nodule (a) and intercostal muscle nodule (b) both contained neoplastic, moderately differentiated gland tissue. There was no excess mucous production. Bone metaplasia was present only in b (a, b hematoxylin-eosin, ×200). c Positivity for cytokeratin-20 immunostaining (×400). d Negativity for cytokeratin-7 immunostaining (×400). e Positivity for CDX2 immunostaining (×200). f Microscopic fi ndings of the intercostal muscle nodule. Slender and atrophic muscle fi bers, close to the metaplastic bone trabeculae and to the neoplastic glands, were highlighted by the anti-desmin antibody (anti-desmin immunostaining, ×200) transthoracic needle aspiration biopsy of a pulmonary neoplasm. 23 There are several interesting clinical and histological aspects of this case: the intramammary localization of one of the two nodules; the long interval after the lung lobectomy; and the presence of bone metaplasia, observed only in the intercostal muscle nodule but absent in the intramammary nodule and in the previously resected specimens of colon carcinoma and lung metastasis. Cartilaginous and/or bone metaplasia have been reported in the rare "matrix-producing" carcinoma, which shows negative immunostaining for ERs, PRs, and HER-2 and positive immunostaining for CK5 expression, and is included within the basal-like phenotype. [6] [7] [8] Although CK7 expression is present in most breast carcinomas, it is noteworthy that it was reported in one case of "matrix-producing" carcinoma 25 and in some metaplastic spindle cell carcinomas. 26 On the contrary, no primary breast carcinomas have been reported to be positive for CK20 immunostaining. Finally, the positive immunostaining for CDX2, a highly sensitive and specifi c marker of colon carcinoma, 27 along with the CK20+/CK7−/CK5− immunohistochemical pattern, made the diagnosis of a primary breast carcinoma unlikely and led us to hypothesize that the patient had double synchronous breast and chest wall metastases of colon adenocarcinoma, one of which had bone metaplasia.
Bone metaplasia is a rare phenomenon more often described in metastasis of colon carcinomas and biliary tract carcinomas. The pathogenesis is still not fully understood, but it is speculated that the extravasation of mucin may play a stimulatory role. 28, 29 It was suggested recently that bone metaplasia may result from the metaplasia of pluripotent stem cells into osteoblast cells induced by bone morphogenetic proteins (BMP-2, -4, -6, -7), 30 among which BMP-2 may play an important paracrine role. 31 In the model designed by Lee et al. 32 to study the early stage of osteoblast differentiation during bone formation in muscle tissues, treatment with BMP-2 not only blocked the myogenic differentiation of C2C12 pluripotent mesenchymal precursor cells but also induced osteoblast differentiation.
Heterotopic ossifi cation in skeletal muscle metastasis from colonic adenocarcinoma has also been reported. 33, 34 However, we observed no excess mucus production in our patient, so a stimulatory role of mucins could not be hypothesized. Furthermore, the presence of mature bone metaplasia next to the muscle fi bers and neoplastic glands suggests a close relationship between these three elements, consistent with the hypothesis of a paracrine mechanism of osteogenesis induction in muscle pluripotent mesenchymal cells by cytokines produced by the neoplastic cells. Further experimental studies to verify this hypothesis are warranted.
Metastatic breast tumors from colon adenocarcinoma are rare and are usually indicative of disseminated disease, with a poor prognosis. [2] [3] [4] However, our patient has no sign of further metastases even after 1.5 years of follow up. This suggests that a metastatic tumor to the breast from colon adenocarcinoma is unlikely, and supports the possibility of a double malignant seeding implantation after the lung metastasis resection. To our knowledge, this is the fi rst report of a synchronous double seeding implantation metastasis along the drainage tube path in the breast parenchyma and in the intercostal muscle, with bone metaplasia. We emphasize the rarity of this case and the peculiarity of the clinical course and histological fi ndings, highlighting the role of CK7, CK20, CK5, and CDX2 immunoassay in the differential diagnosis with a primary breast malignancy.
